Dr. O’Connor invented and pioneered the development of several first in class drugs for the treatment of lymphoma, including one he co-invented for T-cell lymphoma which has now been approved in over 35 countries around the world. He has held several prestigious leadership positions at the major cancer centers in New York City, including Memorial Sloan Kettering Cancer Center, New York University Medical Center, and Cornell and Columbia University Medical Centers.
After earning his Medical Degree from the University of Medicine & Dentistry of New Jersey, Dr. O’Connor went on to undertake his Internship and Residency in Internal Medicine at the New York Hospital/Cornell University Medical Center. He then completed two fellowships, including one in Medical Oncology in the Department of Medicine, under the Clinical Investigator Program (in the laboratory of Dr. Joseph R. Bertino), at Memorial Sloan Kettering Cancer Center, and a second in Clinical Pharmacology in the Division of Pharmacology in the Department of Medicine, New York Hospital – Cornell University Medical School. He was appointed Chief Medical Oncology Fellow, Department of Medicine, Memorial Sloan Kettering Cancer Center.
Dr. O’Connor has published over 200 articles in peer reviewed journals, books and book chapters and reviews on the management of lymphoma. He is the Editor of the first textbook on the Peripheral T-Cell Lymphoma and is now editing a new series of books for Wiley Sciences on Precision Cancer Therapies. He was a member of the Scientific Advisory Board for the Lymphoma Research Foundation, and the Leukemia Lymphoma Society, and has received countless awards for his research, including being named to Americas Top Cancer Doctors, being named among the Top 50 Irish-Americans in Science and Medicine by the Irish government and being inducted into the New Jersey Inventors Hall of Fame. He is also a recipient of the American Cancer Society Research Professorship, the most prestigious honor bestowed by the Society. Dr. O’Connor has been a Castle Connolly Top Doctor since 2011.
He will see patients at White Plains Hospital’s Center for Cancer Care, Suite 300, located at 2 Longview Avenue in White Plains. For appointments and more information, call (914) 849-7630.
About White Plains Hospital
White Plains Hospital is a proud member of the Montefiore Health System, serving as its tertiary hub of advanced care in the Hudson Valley. The Hospital is a 292-bed not-for-profit health care organization with the primary mission of providing exceptional acute and preventive medical care to all people who live in, work in or visit Westchester County and its surrounding areas. Centers of Excellence include the Center for Cancer Care, The William & Sylvia Silberstein Neonatal & Maternity Center and The Ruth and Jerome A. Siegel Stroke Center. The Hospital’s Flanzer Emergency Department is the busiest in Westchester County, with more than 64,000 patient visits a year. White Plains Hospital performs lifesaving emergency and elective angioplasty in its Joan and Alan Herfort, MD, Cardiac Catheterization Laboratory and Marie Promuto Cardiac Catheterization Laboratory. White Plains Hospital has outpatient medical facilities across Westchester, including multispecialty practices in Armonk, New Rochelle, Somers and Yorktown Heights; and Scarsdale Medical Group locations in Harrison and Scarsdale.
The Hospital is fully accredited by the Joint Commission and earned its recognition as a Top Performer for Key Quality Measures® in 2015 and 2013. The Hospital received Magnet® designation in 2012 and 2016 from the American Nurses Credentialing Center (ANCC). The Hospital earned a three-year accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), one of 16 hospitals in the nation, and the Hospital's Bariatric Surgical Center is accredited as a Comprehensive Center under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). White Plains Hospital has also received full accreditation for its breast cancer program from the National Accreditation Program for Breast Centers (NAPBC) and The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) recognized White Plains Hospital as a top 10% performing hospital for achieving meritorious outcomes for surgical patient care in 2019. In 2020, White Plains Hospital received the Outstanding Patient Experience Award from Healthgrades® for the fifth time and, was once again named Best Regional Hospital by U.S. News & World Report. https://www.wphospital.org/about/affiliations-accreditations-awards